CASI Pharmaceuticals

$2.50
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.04 (+1.63%) As of 5:18 PM UTC today

Why Robinhood?

You can buy or sell CASI and other stocks, options, and ETFs commission-free!

About CASI

CASI Pharmaceuticals, Inc. Common Stock, also called CASI Pharmaceuticals, is a biopharmaceutical company, which is focused on the acquisition, development and commercialization of therapeutics addressing cancer and other unmet medical needs. The company develops and commercializes the oncology drugs and drug candidates in China, Taiwan, Hong Kong and Macau. Its products include ZEVALIN, EVOMELA and MARQIBO. CASI Pharmaceuticals was founded in 1991 and is headquartered in Rockville, MD. The listed name for CASI is CASI Pharmaceuticals, Inc. Common Stock.

CEO
Wei-Wu He
Employees
125
Headquarters
Rockville, Maryland
Founded
1991
Market Cap
316.08M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
518.35K
High Today
$2.57
Low Today
$2.47
Open Price
$2.53
Volume
134.01K
52 Week High
$3.90
52 Week Low
$1.15

CASI Earnings

-$0.16
-$0.11
-$0.05
$0.00
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Mar 16, Pre-Market

You May Also Like

GENC
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure